Evanston, IL, United States of America

John Kennedy

This inventor holds 8 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Henry Ford Health System, Itt Corporation, Battelle Energy Alliance, LLC. Active years: 1992-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Kennedy. Retrieved from https://idiyas.com/inventor/john-kennedy-60q51nz1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 319(Granted Patents)


Location History:

  • Boise, ID (US) (1994)
  • Nutley, NJ (US) (1992 - 1995)
  • Lomita, CA (US) (1999)
  • Idaho Falls, ID (US) (2021)
  • Evanston, IL (US) (2015 - 2022)

Company Filing History:


Years Active: 1992-2022

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovator Spotlight: John Kennedy - Pioneering Medical Solutions

Introduction:

John Kennedy, a distinguished inventor based in Evanston, IL, has made significant contributions to the field of healthcare through his innovative patented technologies. With a total of 3 patents to his name, John is known for his advancements in detecting intravascular volume depletion during hemodialysis sessions and determining vascular access risk in a hemodialysis patient population.

Latest Patents:

1. Method for detecting intravascular volume depletion during a hemodialysis session: John's groundbreaking patent involves a method to detect intravascular volume depletion in patients undergoing hemodialysis. By measuring venous drip pressure and analyzing it with a computer-driven analyzer, this invention allows for the automatic and continuous monitoring of venous access pressure, indicating changes in intravascular blood pressure.

2. Method for determining vascular access risk in a hemodialysis patient population: Another notable patent by John focuses on assessing the risk of adverse events associated with vascular access in hemodialysis patients. By evaluating selected risk factors over time, assigning raw scores, and correlating them with the level of risk, this method aids in preemptively identifying and managing potential complications.

Career Highlights:

John Kennedy is affiliated with the Henry Ford Health System, where he continues to drive innovation in medical technology. His expertise and dedication to improving patient care have garnered recognition within the healthcare industry.

Collaborations:

Throughout his career, John has collaborated with esteemed colleagues such as Stanley Frinak and Gerard Zasuwa. Together, they have worked towards pioneering solutions that have the potential to transform the landscape of hemodialysis treatment and patient outcomes.

Conclusion:

In conclusion, John Kennedy stands as a visionary inventor whose inventions have the power to revolutionize the way intravascular volume depletion and vascular access risk are managed in hemodialysis patients. His contributions underscore a commitment to innovation and excellence in healthcare, leaving a lasting impact on the industry and patients alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…